Literature DB >> 18221989

Atherosclerosis in Behçet's Syndrome.

Emire Seyahi1, Serdal Ugurlu, Rana Cumali, Huriye Balci, Oktay Ozdemir, Melike Melikoglu, Gulen Hatemi, Izzet Fresko, Vedat Hamuryudan, Sebahattin Yurdakul, Hasan Yazici.   

Abstract

OBJECTIVES: We had the impression and preliminary evidence that atherosclerosis was not much increased in Behçet's syndrome (BS). Thus, we evaluated the presence of subclinical atherosclerosis in a sizeable group of patients with BS both with major organ involvement and mucocutaneous disease along with diseased and healthy controls.
METHODS: We studied 239 (162 M/ 77 F; mean age: 40.7+/-7.0) patients with BS. Seventy-two (32 M/ 40 F) had only mucocutaneous and/or joint disease and 167 (130 M/ 37 F) had major organ involvement. Also 100 (24 M/ 76 F; mean age: 44.7+/-7.1) patients with rheumatoid arthritis (RA), 74 (58 M/ 16 F; mean age: 39.4+/-7.0) patients with ankylosing spondylitis (AS) and 156 (83 M/ 73 F; mean age: 39.2+/-6.6) healthy controls (HC) were studied as the control groups. We used B-mode USG to assess the frequency of plaques and intima-media thickness (IMT) in the carotid and femoral arteries. Traditional atherosclerotic risk factors were also evaluated. Men and women were analyzed separately.
RESULTS: The frequency of plaques and the mean IMT in the carotid and femoral arteries were similar between patients with BS, AS and HC and also between the 2 subgroups of BS, among both men and women. Only men with RA were found to have significantly increased frequency of carotid artery plaques after adjustment for atherosclerotic risk factors.
CONCLUSION: Increased atherosclerosis is not a prominent feature of BS, even among those patients with major organ involvement.

Entities:  

Mesh:

Year:  2008        PMID: 18221989     DOI: 10.1016/j.semarthrit.2007.09.009

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  24 in total

Review 1.  Behçet's syndrome.

Authors:  Yusuf Yazici; Sebahattin Yurdakul; Hasan Yazici
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

2.  Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease.

Authors:  E Cure; A Icli; A Ugur Uslu; R Aydoğan Baykara; D Sakiz; M Ozucan; F Yavuz; S Arslan; M Cumhur Cure; A Kucuk
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

3.  Low prevalence of obesity in Behçet's disease is associated with high obestatin level.

Authors:  Süleyman Serdar Koca; Murat Kara; Metin Özgen; Ramazan Dayanan; Caner Feyzi Demir; Kader Aksoy; Nevin İlhan; Emir Dönder; Ahmet Işık
Journal:  Eur J Rheumatol       Date:  2017-06-01

4.  Carotid artery stiffness in Behçet's disease.

Authors:  Servet Yolbaş; Nevzat Gözel; Mustafa Necati Dağlı; Süleyman Serdar Koca; Emir Dönder
Journal:  Eur J Rheumatol       Date:  2017-06-01

5.  Cardiovascular risk and inflammation in rheumatic diseases.

Authors:  Armen Yuri Gasparyan
Journal:  Rheumatol Int       Date:  2017-01       Impact factor: 2.631

6.  A novel atherogenic epitope from Mycobacterium tuberculosis heat shock protein 65 enhances atherosclerosis in rabbit and LDL receptor-deficient mice.

Authors:  Yu Zhang; Qiyan Xiong; Xiangbing Hu; Yunxiao Sun; Xiying Tan; Huiyong Zhang; Yong Lu; Jingjing Liu
Journal:  Heart Vessels       Date:  2011-10-29       Impact factor: 2.037

7.  Levels of F2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors.

Authors:  Gul Sagun; Aytekin Oguz; Banu Mesci; Banu Isbilen; Mukaddes Kavala; Havva Keskin; Mumtaz Takir; Sibel Zehra Aydin
Journal:  Redox Rep       Date:  2015-04-13       Impact factor: 4.412

8.  Myocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis.

Authors:  Giuseppe Cocco; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

9.  Behçet's Disease: an Insight from a Cardiologist's Point of View.

Authors:  Giuseppe Cocco; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 10.  Differential diagnosis and management of Behçet syndrome.

Authors:  Nicola L Ambrose; Dorian O Haskard
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.